Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
ClinicalTrials.gov study NCT01744691. IPD Sharing: NO. Countries: 9. Publications: 1.
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
ClinicalTrials.gov study NCT03580928. IPD Sharing: NO. Countries: 1. Publications: 2.
Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
ClinicalTrials.gov study NCT00410163. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
ClinicalTrials.gov study NCT00910910. IPD Sharing: Not stated. Countries: 27. Publications: 1.
A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
ClinicalTrials.gov study NCT02514083. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL
ClinicalTrials.gov study NCT01217749. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01292135. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
ClinicalTrials.gov study NCT01465334. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
ClinicalTrials.gov study NCT00774345. IPD Sharing: Not stated. Countries: 25. Publications: 1.
Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.
ClinicalTrials.gov study NCT02315768. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
ClinicalTrials.gov study NCT03534323. IPD Sharing: NO. Countries: 1. Publications: 0.
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
ClinicalTrials.gov study NCT02475681. IPD Sharing: YES. Countries: 18. Publications: 3.
Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL
ClinicalTrials.gov study NCT01994382. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safe Accelerated Venetoclax Escalation in CLL
ClinicalTrials.gov study NCT04843904. IPD Sharing: YES. Countries: 1. Publications: 0.
A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01539512. IPD Sharing: YES. Countries: 5. Publications: 3.
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01010568. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02320487. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02477696. IPD Sharing: YES. Countries: 15. Publications: 6.
A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02801578. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)
ClinicalTrials.gov study NCT03685708. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.